A new paradigm for preventing and treating neurodegeneration

Acelot is a development stage biopharmaceutical company focused on therapies for neurodegenerative disorders.

A Unified Approach

Our novel machine learning and in vitro assay platform identifies small molecules that act specifically upon toxic forms of proteins found in neurodegenerative diseases.

Our Team

Katie Planey


Leader in building data-driven biotech companies

Ambuj Singh

Founder, PhD

UCSB Computer Science Professor with research expertise in machine learning applied to biology and chemistry

Lewis Whitehead

VP of Research, Computational Discovery

Computational medicinal chemist with expertise in small molecule drug discovery

Vidhu Mathur

Director of Research, Preclinical, PhD

Neurodegenerative preclinical research expert

Eric Shao

Senior Scientist I, PhD

Expert in molecular biology and tau-targeting therapies

Marcela Kokes

Senior Scientist I, PhD

Expert in cell biology and mechanistic biology

Shruti Arya

Senior Scientist I, PhD

Expert in protein biophysics/biochemistry and molecular mechanisms of neurodegenerative diseases

Kevin Burk

Data Scientist, MS

Software and machine learning expert

Cody Aldaz

Data Scientist

Expert in theoretical chemistry and deep learning